Covered recipient · General Payments record
WALLACE L FRITZ
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,489.31
- Reported across 122 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $420.28 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $144.01 | 11 |
| Novo Nordisk AS | $53.74 | 3 |
| Astellas Pharma US Inc | $48.08 | 3 |
| Daiichi Sankyo Inc. | $35.25 | 2 |
| Merck Sharp & Dohme Corporation | $32.17 | 2 |
| Amgen Inc. | $31.05 | 2 |
| PFIZER INC. | $28.72 | 2 |
| Lilly USA, LLC | $18.52 | 1 |
| Janssen Pharmaceuticals, Inc | $15.27 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.47 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2018201920212023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $12.32 | 01/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103757571 | CMS |
| ABBVIE INC. | $15.68 | 02/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103757573 | CMS |
| ABBVIE INC. | $12.23 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103757575 | CMS |
| ABBVIE INC. | $14.29 | 04/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103757577 | CMS |
| ABBVIE INC. | $15.28 | 05/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103757579 | CMS |
| ABBVIE INC. | $12.59 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103757581 | CMS |
| ABBVIE INC. | $17.01 | 06/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103757583 | CMS |
| ABBVIE INC. | $12.83 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103757585 | CMS |
| ABBVIE INC. | $12.36 | 10/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103757587 | CMS |
| ABBVIE INC. | $8.70 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103757589 | CMS |
| ABBVIE INC. | $10.72 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103757591 | CMS |
| Amgen Inc. | $14.16 | 08/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115637666 | CMS |
| Amgen Inc. | $16.89 | 12/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115637673 | CMS |
| Astellas Pharma US Inc | $16.53 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139272048 | CMS |
| Astellas Pharma US Inc | $14.44 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139300996 | CMS |
| Astellas Pharma US Inc | $17.11 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139445246 | CMS |
| Daiichi Sankyo Inc. | $16.19 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089423235 | CMS |
| Daiichi Sankyo Inc. | $19.06 | 10/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089423231 | CMS |
| Janssen Pharmaceuticals, Inc | $15.27 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1078180401 | CMS |
| Lilly USA, LLC | $18.52 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135476234 | CMS |
| Merck Sharp & Dohme LLC | $15.57 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141967939 | CMS |
| Merck Sharp & Dohme LLC | $16.60 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141960306 | CMS |
| Novo Nordisk Inc | $20.22 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096867165 | CMS |
| Novo Nordisk Inc | $14.40 | 10/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096597448 | CMS |
| Novo Nordisk Inc | $19.12 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096641844 | CMS |
| PFIZER INC. | $14.43 | 02/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131119560 | CMS |
| PFIZER INC. | $14.29 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131451339 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $13.47 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137550782 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2021, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.